Skip to main content
Erschienen in: Neurocritical Care 1/2022

Open Access 23.02.2022 | Original work

Cerebrospinal Fluid and Arterial Acid–Base Equilibrium of Spontaneously Breathing Patients with Aneurismal Subarachnoid Hemorrhage

verfasst von: Thomas Langer, Francesco Zadek, Marco Carbonara, Alessio Caccioppola, Serena Brusatori, Tommaso Zoerle, Francesco Bottazzini, Chiara Ferraris Fusarini, Adriana di Modugno, Alberto Zanella, Elisa R. Zanier, Roberto Fumagalli, Antonio Pesenti, Nino Stocchetti

Erschienen in: Neurocritical Care | Ausgabe 1/2022

Abstract

Background

Hyperventilation resulting in hypocapnic alkalosis (HA) is frequently encountered in spontaneously breathing patients with acute cerebrovascular conditions. The underlying mechanisms of this respiratory response have not been fully elucidated. The present study describes, applying the physical–chemical approach, the acid-base characteristics of cerebrospinal fluid (CSF) and arterial plasma of spontaneously breathing patients with aneurismal subarachnoid hemorrhage (SAH) and compares these results with those of control patients. Moreover, it investigates the pathophysiologic mechanisms leading to HA in SAH.

Methods

Patients with SAH admitted to the neurological intensive care unit and patients (American Society of Anesthesiologists physical status of 1 and 2) undergoing elective surgery under spinal anesthesia were enrolled. CSF and arterial samples were collected simultaneously. Electrolytes, strong ion difference (SID), partial pressure of carbon dioxide (PCO2), weak noncarbonic acids (ATOT), and pH were measured in CSF and arterial blood samples.

Results

Twenty spontaneously breathing patients with SAH and 25 controls were enrolled. The CSF of patients with SAH, as compared with controls, was characterized by a lower SID (23.1 ± 2.3 vs. 26.5 ± 1.4 mmol/L, p < 0.001) and PCO2 (40 ± 4 vs. 46 ± 3 mm Hg, p < 0.001), whereas no differences in ATOT (1.2 ± 0.5 vs. 1.2 ± 0.2 mmol/L, p = 0.95) and pH (7.34 ± 0.06 vs. 7.35 ± 0.02, p = 0.69) were observed. The reduced CSF SID was mainly caused by a higher lactate concentration (3.3 ± 1.3 vs. 1.4 ± 0.2 mmol/L, p < 0.001). A linear association (r = 0.71, p < 0.001) was found between CSF SID and arterial PCO2. A higher proportion of patients with SAH were characterized by arterial HA, as compared with controls (40 vs. 4%, p = 0.003). A reduced CSF-to-plasma difference in PCO2 was observed in nonhyperventilating patients with SAH (0.4 ± 3.8 vs. 7.8 ± 3.7 mm Hg, p < 0.001).

Conclusions

Patients with SAH have a reduction of CSF SID due to an increased lactate concentration. The resulting localized acidifying effect is compensated by CSF hypocapnia, yielding normal CSF pH values and resulting in a higher incidence of arterial HA.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s12028-022-01450-1.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

According to Stewart’s physical–chemical approach [1], the acid–base equilibrium of biological fluids is regulated independently by three variables: the partial pressure of carbon dioxide (PCO2), the strong ion difference (SID), and the total amount of weak nonvolatile buffers (ATOT). Cerebrospinal fluid (CSF) in normal conditions is a clear fluid surrounding the brain, characterized by a very low concentration of proteins. It is produced mainly by the choroid plexus and reabsorbed by the arachnoid villi [2]. Given its negligible amount of proteins, only two variables regulate the acid–base equilibrium of CSF, namely PCO2 and SID [3]. The acid–base equilibrium of this small and very particular extracellular fluid compartment, i.e., CSF, is of particular importance because it contributes significantly to the regulation of cerebral blood flow [4] and spontaneous breathing activity [5].
Hyperventilation resulting in hypocapnic alkalosis (HA) is frequently encountered in spontaneously breathing patients with acute cerebrovascular conditions [68] or severe brain injuries [9]. The pathophysiologic mechanisms underlying this abnormal respiratory response have not been fully elucidated. On one hand, the existence of a neurogenic stimulus causing a pathologic activation of the respiratory centers has been hypothesized [8, 10, 11]. On the other hand, the mixing of CSF with exogenous blood could determine an acidification of the extracellular cerebral milieu, fostering an increase in minute ventilation to restore normal pH values in proximity of the respiratory centers [7].
The aim of the present study was to (1) describe, applying Stewart’s physical–chemical approach, the acid–base characteristics of CSF and arterial plasma of spontaneously breathing patients with subarachnoid hemorrhage (SAH); (2) compare these results with those of healthy controls; and (3) investigate the pathophysiologic mechanisms leading to HA in SAH. We hypothesized that patients with SAH would be characterized by a local CSF metabolic acidosis (lower CSF SID), which would favor the development of hypocapnia.

Methods

Institutional Review Board and Patient Consent

The study protocol and the informed consent process were approved by the Ethical Committee Milano Area B (protocol number: 25_2017bis), and written informed or deferred consent was obtained from patients with SAH and controls.

Patients with Spontaneous SAH

Patients with SAH admitted to the neurological intensive care unit (ICU) of our hospital, in whom an external ventricular drain was placed for clinical reasons, with preserved spontaneous respiratory activity were enrolled. Details about our clinical practice regarding SAH treatment can be found elsewhere [12]. Both nonintubated patients and intubated patients on pressure support ventilation were studied. Age younger than 18 years and pregnancy constituted exclusion criteria. In each patient, CSF and arterial blood samples were collected simultaneously as close as possible to the day of SAH onset. A CSF sample of 1.5 mL was drawn anaerobically and under strict asepsis from the external ventricular drain after the dead space of the catheter was discarded. Simultaneously, an arterial blood sample was collected from an indwelling arterial catheter. In addition, the following clinical data were recorded: medical history, the severity of bleeding (modified Fisher scale), day from bleeding, neurological assessment at ICU admission (World Federation Neurological Surgeons Scale), and Glasgow Coma Scale score on the study day [13].

Control Population

Patients undergoing spinal anesthesia for elective surgery constituted the control group. Exclusion criteria were American Society of Anesthesia (ASA) physical status above 2, age younger than 18, pregnancy, and known neurological, renal, or respiratory disease. Before the local anesthetic injection, 1.5 mL of CSF was collected anaerobically from the needle used for spinal anesthesia. The radial artery was punctured to collect an arterial blood sample. Anesthesiologists were asked to limit intravenous fluids prior to spinal anesthesia and to choose balanced solutions to avoid intravenous-fluids-related acid–base derangements [14, 15].

Analysis of CSF and Blood

Acid–base and electrolytes of CSF and arterial blood samples were immediately measured (ABL800 FLEX, Radiometer, Copenhagen, Denmark). Magnesium, phosphate, and albumin levels (COBAS 8000, Roche Diagnostics GmbH, Mannheim, Germany); hemoglobin concentration; and red and white blood cell counts (XN-9000 V, Sysmex Corporation, Kobe, Japan) were analyzed for CSF and blood samples. Plasma and CSF osmolarity were measured (Osmometer MIR 300-P, E. Mires, Milan, Italy).
For each CSF and blood sample, the SID was calculated as indicated in Eq. 1 [16]:
$$SID = \left[ {Na^{ + } \left] { + } \right[K^{ + } \left] { + 2 \times } \right[Ca^{2 + } \left] { + 2 \times } \right[Mg^{2 + } \left] { - } \right[Cl^{ - } \left] { - } \right[Lac^{ - } } \right],$$
(1)
where Na+, K+, Ca2+, Cl, and Lac refer to plasma sodium, potassium, ionized calcium, chloride, and lactate concentrations expressed as millimolar.
Moreover, the dissociated part of noncarbonic weak acid was computed using Eq. 2 [16]:
$$\left[ {A^{ - } } \right] = \left[ {Alb} \right] \times \;\left( {pH \times \;0.1204 - 0.625} \right) + \left[ {Pi} \right] \times \;\left( {pH \times \;0.309 - 0.469} \right),$$
(2)
where [A] is expressed in mmol/L, [Alb] is the plasma concentration of albumin expressed in g/L, [Pi] is the plasma concentration of phosphates expressed in mmol/L, and pH denotes arterial or cerebrospinal pH.
The total amount of weak acids [ATOT] was calculated, rearranging the dissociation equation as reported in Eq. 3:
$$[A_{TOT} ] = [A^{ - } ] \times \;\frac{{1 + 10^{{(pH - pK_{A} )}} }}{{10^{{(pH - pK_{A} )}} }},$$
(3)
where pH is the arterial or cerebrospinal pH, and pKA is equal to 6.8 and represents the negative logarithm to base 10 of the dissociation constant of noncarbonic buffers.
The difference between CSF and plasma SID and CSF and plasma PCO2 was computed and termed ΔSID and ΔPCO2, respectively.
$$\Delta SID \left[ {mmol/L} \right] = \left[ {SID} \right]_{CSF } - \left[ {SID} \right]_{Pl}$$
(4)
$${\Delta }PCO_{2} \left[ {mm\ Hg} \right] = PCO_{2\, CSF} - PCO_{2\, Pl}$$
(5)
The ratios between CSF and arterial plasma were calculated as previously described [11].
$$Ratio = [\ ]_{CSF} /[\ ]_{Pl}$$
(6)
Bicarbonate ion concentration ([HCO3]) was calculated from pH and PCO2 according to the Henderson–Hasselbalch equation (\(pH\; = \;pK\; + \;\log_{10} \frac{{[HCO_{3}^{ - } ]}}{{\alpha \ \times \;PCO_{2} }}\)), assuming pK = 6.1 and α = 0.0306 for plasma and pK = 6.13 and α = 0.0318 for CSF [17].
$$HCO_{3}^{ - } = \alpha \times PCO_{2} \times 10^{{\left( {pH {-} pK} \right)}}$$
(7)

Clinical Definition of HA

Patients with an arterial PCO2 < 35 mm Hg and an arterial pH > 7.45 were included in the HA subgroup, whereas patients who did not present these features were included in the subgroup without HA.

Clinical Outcomes

The Glasgow Outcome Scale Extended (GOS-E) [18, 19] was scored at 12 months. A good clinical outcome was defined as a GOS-E score ≥ 6. Information regarding clinical outcome was gathered over the phone, directly, or through the caregiver. Data about the incidence of clinical vasospasm, defined as new neurological symptoms associated with confirmed vasospasm diagnosed by a neuroradiologist [20], were collected from the patients’ medical charts.

Sample Size and Statistical Analysis

Data analysis and statistical plans were written and filed with the institutional review board before data were accessed. We calculated that a sample of 40 patients (20 patients per group) would provide a statistical power of 0.9 with an α error of 0.05 to detect a difference in SID of 3 mEq/L, assuming a standard deviation of 2.5 mEq/L. Given the novelty of the measurement of some CSF variables, we decided to increase the number of control patients to 25.
Comparison between continuous variables was performed via Student’s t-test or the Mann–Whitney rank-sum test, as appropriate. Differences between categorical variables were assessed using the χ2 test. The relationship between quantitative or categorical variables was investigated using linear and multilinear regression, as appropriate. Data are expressed as mean ± standard deviation or median and interquartile range, unless otherwise stated. Statistical significance was defined as p < 0.05. Analysis was performed with SAS v.9.2 (SAS Institute, Inc., Cary, NC) and SigmaPlot v.12.0 (Systat Software, San Jose, CA). The Strengthening the Reporting of Observational Studies in Epidemiology checklist was used.

Results

Description of the Study Population

Patients were enrolled between February 2017 and October 2018. Twenty spontaneously breathing patients with aneurismal SAH (aged 57 ± 11 years, 16 women, body mass index 25 [2329]) were enrolled and studied on day 2 (2–4) after bleeding. The median World Federation Neurological Surgeons Scale score at ICU admission was 3.5 (1–4), the median modified Fisher scale score was 4 (3–4), and the median Glasgow Coma Scale core on the study day was 12 (9–15). Ten patients were not intubated and were spontaneously breathing. The remaining ten were intubated on pressure support ventilation. At the sampling time, no patient exhibited neurogenic breathing patterns [21] or hypoxic respiratory failure (PaO2/FiO2 = 352 ± 121). Twenty-five healthy controls were enrolled (aged 56 ± 16 years, 9 women, body mass index 24 [2325], 8 patients with an ASA physical status of 1, 17 patients with an ASA physical status of 2). The only statistically significant difference found between controls and patients with SAH was a higher prevalence of female sex in patients with SAH (80% vs. 36%, p = 0.004). Comorbidities of patients with SAH and controls are reported in Table S1.

Description of Cerebrospinal and Arterial Acid–Base Characteristics

Cerebrospinal and arterial acid–base findings are summarized in Tables 1 and 2. CSF of patients with SAH was characterized by an increased presence of red and white blood cells, whereas no red blood cells and only 2 ± 2 white blood cells per microliter were found in controls. The CSF of patients with SAH, as compared with controls, had lower SID and PCO2 and similar ATOT. No difference in CSF pH was observed. The reduced CSF SID was caused mainly by an increased lactate concentration (p < 0.001). On the plasma side (Table 2), similar SID and PCO2 values were recorded. The plasma of patients with SAH was characterized by lower ATOT, as compared with controls, leading to a significantly higher arterial pH. The reduction in ATOT observed in patients with SAH was caused both by lower albumin (4.2 ± 0.4 vs. 3.5 ± 0.4 g/dL, p < 0.001) and phosphate (3.2 ± 0.6 vs. 2.5 ± 0.8 mg/dL, p = 0.003) concentrations.
Table 1
Acid–base characteristics of cerebrospinal fluid of the study population
Variables
Controls (n = 25)
SAH (n = 20)
p value
pH
7.35 ± 0.02
7.34 ± 0.06
0.69
PCO2 (mm Hg)
46 ± 3
40 ± 4
 < 0.001
ATOT (mmol/L)
1.2 ± 0.2
1.2 ± 0.5
0.95
SID (mmol/L)
26.5 ± 1.4
23.1 ± 2.3
 < 0.001
Na+ (mmol/L)
141 ± 1
143 ± 3
0.007
K+ (mmol/L)
2.8 ± 0.1
2.6 ± 0.5
0.07
Ca2+ (mmol/L)
0.99 ± 0.02
0.98 ± 0.06
0.22
Mg2+ (mmol/L)
1.10 ± 0.04
1.15 ± 0.06
0.002
Cl (mmol/L)
120 ± 2
123 ± 4
0.001
Lac (mmol/L)
1.4 ± 0.2
3.3 ± 1.3
 < 0.001
HCO3 (mmol/L)
24.7 ± 1.5
21.7 ± 2.4
 < 0.001
Phosph (mEq/L)
0.77 ± 0.08
0.66 ± 0.20
0.02
Alb (mEq/L)
0.19 ± 0.14
0.30 ± 0.23
0.05
Osmolarity (mOsm/L)
285 ± 3
290 ± 7
0.001
Gluc (mg/dL)
59 ± 7
74 ± 14
 < 0.001
Hb (g/dL)
0.0 ± 0.0
0.3 ± 0.3
 < 0.001
RBC (× 106/µL)
0.00 ± 0.00
0.11 ± 0.12
 < 0.001
WBC (cells/µL)
2 ± 2
359 ± 562
0.003
Data are expressed as mean ± standard deviation
Alb, ionized albumin concentration, ATOT, total amount of weak noncarbonic acids, Ca2+, ionized calcium concentration, Cl, chloride concentration, Gluc, glucose concentration, Hb, hemoglobin concentration, HCO3, bicarbonate concentration, K+, potassium concentration, Lac, lactate concentration, Mg2+, magnesium concentration, Na+, sodium concentration, PCO2, partial pressure of carbon dioxide, Phosph, ionized phosphate concentration, RBC, red blood cell count, SAH, aneurismal subarachnoid hemorrhage, SID, strong ion difference, WBC, white blood cell count
Table 2
Acid–base characteristics of arterial plasma of the study population
Variables
Controls (n = 25)
SAH (n = 20)
p value
pH
7.42 ± 0.02
7.45 ± 0.04
 < 0.001
PCO2 (mm Hg)
39 ± 3
37 ± 6
0.15
ATOT (mmol/L)
16.3 ± 1.5
13.5 ± 1.6
 < 0.001
SID (mmol/L)
36.2 ± 1.8
37.2 ± 3.7
0.23
PO2 (mm Hg)
99 ± 49
111 ± 28
0.35
Na+ (mmol/L)
138 ± 2
142 ± 4
 < 0.001
K+ (mmol/L)
4.0 ± 0.3
3.5 ± 0.2
 < 0.001
Ca2+ (mmol/L)
1.22 ± 0.03
1.17 ± 0.04
 < 0.001
Mg2+ (mmol/L)
0.84 ± 0.07
0.85 ± 0.07
0.88
Cl (mmol/L)
109 ± 2
111 ± 5
0.03
Lac (mmol/L)
1.1 ± 0.4
1.0 ± 0.5
0.25
HCO3 (mmol/L)
25.0 ± 2.0
25.5 ± 2.9
0.19
Phosph (mEq/L)
1.9 ± 0.3
1.5 ± 0.5
0.004
Alb (mEq/L)
11.3 ± 1.1
9.6 ± 1.1
 < 0.001
SBE (mmol/L)
0.5 ± 2.0
1.6 ± 2.6
0.09
Osmolarity (mOsm/L)
281 ± 3
291 ± 8
 < 0.001
Gluc (mg/dL)
100 ± 11
129 ± 20
 < 0.001
Gluc ratio (%)
59 ± 6
58 ± 8
0.55
Hb (g/dL)
14.0 ± 1.6
11.4 ± 1.6
 < 0.001
RBC (× 106/µL)
4.5 ± 0.5
3.6 ± 0.7
 < 0.001
WBC (× 103/µL)
5.9 ± 1.0
10.2 ± 2.4
 < 0.001
Data are expressed as mean ± standard deviation
Alb, ionized albumin concentration, ATOT, total amount of weak noncarbonic acids, Ca2+, ionized calcium concentration, Cl, chloride concentration, Gluc, glucose concentration, Hb, hemoglobin concentration, HCO3, bicarbonate concentration, K+, potassium concentration, Lac, lactate concentration, Mg2+, magnesium concentration, Na+, sodium concentration, PCO2, partial pressure of carbon dioxide, Phosph, ionized phosphate concentration, PO2, partial pressure of oxygen, RBC, red blood cell count, SAH, aneurismal subarachnoid hemorrhage, SBE, standard base excess, SID, strong ion difference, WBC, white blood cell count
The ΔSID, i.e., the difference between CSF and plasma SID, differed significantly between the two groups (Fig. 1). Furthermore, ΔPCO2, the CSF-to-plasma difference in PCO2, showed significantly different values between controls and patients with SAH (7.5 ± 2.5 vs. 3.4 ± 5.2 mm Hg, p = 0.001). Measured osmolarity of both plasma (p < 0.001) and CSF (p = 0.001) was significantly higher in patients with SAH.

HA and Underlying Mechanisms

The incidence of HA was higher in spontaneously breathing patients with SAH, as compared with controls (40% vs. 4%, p = 0.003).
When comparing hypocapnic and nonhypocapnic patients with SAH, no differences in demographic and clinical variables were observed (Table S2). Arterial and CSF acid–base characteristics of patients with HA and those without HA are summarized in Table S3 and Table 3, respectively.
Table 3
Acid–base characteristics of cerebrospinal fluid of the SAH population
Variables
Nonhypocapnic alkalosis (n = 12)
Hypocapnic alkalosis (n = 8)
p value
pH
7.36 ± 0.05
7.33 ± 0.06
0.26
PCO2 (mm Hg)
41 ± 4
39 ± 4
0.47
ATOT (mmol/L)
1.3 ± 0.5
1.1 ± 0.3
0.18
SID (mmol/L)
24.2 ± 1.7
21.3 ± 1.9
0.002
Na+ (mmol/L)
143 ± 5
143 ± 1
0.98
K+ (mmol/L)
2.5 ± 0.4
2.6 ± 0.7
0.78
Ca2+ (mmol/L)
1.00 ± 0.04
0.96 ± 0.07
0.11
Mg2+ (mmol/L)
1.17 ± 0.07
1.13 ± 0.04
0.15
Cl (mmol/L)
122 ± 5
125 ± 3
0.13
Lac (mmol/L)
3.4 ± 1.4
3.1 ± 1.2
0.60
HCO3 (mmol/L)
22.7 ± 2.1
20.4 ± 2.3
0.03
Phosph (mEq/L)
0.68 ± 0.23
0.62 ± 0.17
0.56
Alb (mEq/L)
0.37 ± 0.26
0.19 ± 0.12
0.09
Osmolarity (mOsm/L)
290 ± 9
290 ± 2
0.95
Gluc (mg/dL)
73 ± 15
76 ± 14
0.72
Hb (g/dL)
0.4 ± 0.4
0.3 ± 0.3
0.70
RBC (× 106/µL)
0.12 ± 0.14
0.09 ± 0.07
0.59
WBC (cells/µL)
326 ± 572
408 ± 588
0.76
ΔSID (mmol/L)
14.4 ± 3.7
13.8 ± 1.2
0.65
ΔPCO2 (mm Hg)
0.4 ± 3.8
7.8 ± 3.7
 < 0.001
Data are expressed as mean ± standard deviation
Alb, ionized albumin concentration, ATOT, total amount of weak noncarbonic acids, Ca2+, ionized calcium concentration, Cl, chloride concentration, Gluc, glucose concentration, Hb, hemoglobin concentration, HCO3, bicarbonate concentration, K+, potassium concentration, Mg2+, magnesium concentration, Na+, sodium concentration, PCO2, partial pressure of carbon dioxide, Phosph, ionized phosphate concentration, RBC, red blood cell count, SAH, aneurismal subarachnoid hemorrhage, SID, strong ion difference, WBC, white blood cell count
Although CSF SID was lower (p = 0.002) in patients with HA, CSF PCO2 and pH did not differ significantly between groups. Notably, CSF electrolytes did not differ significantly between patients with HA and those without HA. Regarding plasma, in addition to the differences in PCO2 and pH due to the selection criteria, arterial SID was significantly lower in patients with HA.
A lower ΔPCO2 was measured in patients without HA compared with those with HA (Table 3). Of note, the ΔPCO2 of patients with HA was similar to values measured in the control group (p = 0.78).

The Interplay Between Variables and pH

Linear and multilinear regression analyses were used to investigate the association between variables both in controls and in patients with SAH. In controls, no association was found at univariate analysis between CSF SID (p = 0.93) or CSF PCO2 (p = 0.13) and CSF pH.
In patients with SAH, both CSF SID and PCO2 showed a significant association with CSF pH (r = 0.54 [p = 0.01] and r =  − 0.59 [p = 0.006], respectively). Both variables remained independently associated at the multilinear regression analysis (r2 = 0.79, p < 0.001; Table S4). At univariate analysis, CSF sodium (r =  − 0.55, p = 0.01), chloride (r =  − 0.62, p = 0.003), and lactate (r =  − 0.60, p = 0.005) were significantly associated with CSF pH. However, at multilinear regression analysis, only lactate was independently associated with CSF pH (Table S5). Lastly, in the overall SAH population, a positive correlation between CSF SID and arterial PCO2 was found (Fig. 2). Similarly, a negative correlation between CSF SID and arterial pH was observed (r =  − 0.62, p < 0.004; Fig. S1).

Clinical Outcome

Six patients with SAH experienced an episode of clinical vasospasm; two of these patients died in the ICU, and four patients were lost at follow-up. Plasma and CSF acid–base characteristics of patients who developed vasospasm did not differ significantly from those of patients who did not (Tables S6 and S7). No significant association was observed between CSF SID (or ΔSID) and the modified Fisher scale score by Pearson’s correlation (data not shown). The median 12-month GOS-E score was 6 (3–8). No difference (p = 0.64) was observed in GOS-E scores between patients with HA and those without HA. A good clinical outcome (GOS-E score ≥ 6) was observed in 10 of 16 patients. Patients with worse clinical outcomes had higher CSF lactate concentrations (4.5 ± 1.4 vs. 2.7 ± 0.9, p = 0.006).

Discussion

In the present study, we used the physicochemical approach to acid–base [1] to describe the acid–base characteristics of both arterial blood and CSF of spontaneously breathing patients with SAH and compared these results with those of a control population, i.e., healthy, spontaneously breathing patients undergoing elective surgery under spinal anesthesia. The main finding of our study was that patients with SAH had lower CSF SID, mainly due to an increased concentration of lactate. Arterial SID did not differ between the two populations. Therefore, when blood SID was subtracted from CSF SID (ΔSID), significantly different values were observed in patients with SAH and controls (Fig. 1). This finding clearly points toward a primary metabolic acid–base disorder caused by intracranial bleeding and compartmentalized in the cerebral/CSF environment. Despite the acidifying effect of a reduced CSF SID, CSF pH was similar in the two populations, as CSF PCO2 was significantly reduced in patients with SAH. The respiratory compensation of this local metabolic acidosis led to blood HA in 40% of the SAH population.
Isolated CSF acidosis has been induced in several animal models [2225] by directly injecting acids into the ventricular system. In these studies, local CSF acidification triggered the respiratory chemoreceptors and caused an increase in minute ventilation to restore CSF pH through a reduction in CSF PCO2 [22]. Given the anatomical and functional separation between blood and CSF, the acids injected locally did not reach the bloodstream, which was therefore unaffected by the acid–base disorder. Consequently, the compensatory hyperventilation corrected CSF pH and led to a systemic HA of the blood.
Although the presence of HA frequently characterizes patients with cerebrovascular conditions, only a few reports [5, 11, 26] investigated the underlying mechanisms. We hypothesized that a local CSF metabolic acidosis, i.e., a reduction in CSF SID, could partially explain the finding. We therefore studied the blood/CSF electrolytes and acid–base of healthy patients undergoing spinal anesthesia and considered these data, for the present study, as baseline values, i.e., normal reference values before the SAH.
Our results from the control population regarding CSF electrolytes and acid–base variables are in line with the available literature [11, 2729]: normal CSF has a pH around 7.35 with a SID close to 26 mmol/L. In CSF, the protein concentration is negligible, and electrical neutrality is guaranteed by a higher chloride concentration as compared with plasma (120 vs. 109 mmol/L).
The CSF acid–base characteristics of patients with SAH differed significantly as compared with controls. In particular, in patients with SAH, we observed a lower CSF SID, which favors acidification. The causes of the reduced SID are likely multifactorial. First, spontaneous SAH causes the sudden release of blood in the subarachnoid space, frequently including the cerebral ventricles. Although blood has a higher pH and SID, as compared with CSF (Tables 1 and 2), the presence of living red blood cells reaching the CSF could increase CSF lactate concentration because of their anaerobic metabolism [7]. Second, cerebrovascular events frequently lead to cerebral hypoperfusion/ischemia fostering the release of metabolites (mainly lactate) from suffering cerebral tissue [3033]. Finally, therapies administered in the critical care setting might affect the electrolyte composition of the extracellular fluid, including CSF. Indeed, although the increase in CSF lactate concentration observed in our patients was a consequence of SAH, the alterations of other electrolytes, such as sodium and chloride, could be secondary to the use of isotonic/hypertonic NaCl or other crystalloids. Despite the difference in CSF SID, CSF pH did not differ between the two populations because CSF PCO2 was lower in patients with SAH. This finding might be interpreted as a compensatory hyperventilation triggered by the local CSF acidification.
Similar considerations can be made when analyzing the differences in arterial blood composition (Table 2). Indeed, some differences are likely a consequence of medical treatment. For instance, we observed higher concentrations of sodium and chloride and lower concentrations of albumin, hemoglobin, and phosphates. All these findings can be attributed (at least in part) to intravenous fluids with slightly hypertonic, chloride-rich fluids. In this population, supranormal sodium concentrations and plasma osmolarity are therapeutic targets to reduce the cerebral swelling risk [34]. Overall, the plasma SID of patients with SAH was similar to that of controls. On the other hand, patients with SAH had lower concentrations of weak noncarbonic acids, mainly due to hypoalbuminemia. According to Stewart’s approach, a decrease in weak noncarbonic acids unbalances the acid–base equilibrium toward alkalosis. Of note, hypoalbuminemia is very frequent in critically ill patients [35], in particular in patients with neurologic disorders, given the relative contraindication to its exogenous supplementation [36, 37].
Patients were divided according to the presence/absence of HA (Table 3). This condition was frequent (40%) in patients with SAH, whereas it was present only in one control patient. Per definition, patients with HA had lower arterial PCO2 and higher arterial pH. Moreover, patients with HA had a lower arterial SID, mainly due to a higher chloride concentration. It is conceivable that the renal compensation of HA might have contributed to this finding [38].
On the CSF side, patients with HA had significantly lower CSF SID as compared with nonhypocapnic patients. The reduced SID was not attributable to a single major electrolyte derangement: several nonsignificant electrolyte differences were observed.
Another striking difference between patients with HA and those without HA was ΔPCO2, i.e., the CSF-to-plasma difference in PCO2. In patients with HA, ΔPCO2 had normal values, i.e., values similar to those of controls. On the contrary, ΔPCO2 was significantly reduced in patients without HA (Table 3). Sambrook et al. [11] already described a reduced ΔPCO2 in a case series of patients with SAH, and a reduction of cerebral metabolism was hypothesized to explain this finding [32, 39]. A possible interpretation is the following: a lower cerebral metabolism could characterize patients without HA, leading to a lower local carbon dioxide production and thus a lower difference in PCO2 as compared with arterial blood. Consequently, in patients without HA, CSF pH is close to normal as a result of a lower CSF SID and lower CSF PCO2. Apparently, however, the lower CSF PCO2 is not the result of hyperventilation, because arterial PCO2 is normal, but could be the expression of a reduced local carbon dioxide production. Of note, using positron emission tomography, Carpenter and colleagues [39] documented a reduced cerebral metabolism in patients with SAH.
We used linear and multilinear regression analyses to investigate the association between acid–base variables in the two extracellular compartments. Interestingly, no linear association was found in controls between both CSF PCO2 and SID and CSF pH, suggesting the presence of a stable physiologic equilibrium. On the contrary, in patients with SAH, there was an association between both CSF SID and PCO2 and CSF pH at linear and multilinear regression. Interestingly, only lactate was independently associated with CSF pH at multilinear regression. In the overall SAH population, CSF SID was linearly correlated with both arterial PCO2 (Fig. 2) and pH, suggesting its key role in determining the CSF acid–base disorder and thus favoring the respiratory compensation.

Clinical Implications and Future steps

The presence of hypocapnia in patients with SAH has been hypothesized to be a marker of severity and to be associated with worse outcomes [40]. The idea is that a primary hyperventilation might lead to cerebral hypocapnia and alkalosis, leading to a reduced cerebral blood flow and possibly fostering the development of vasospasm. We did not find any difference regarding clinical outcomes between patients with HA and those without HA. Similarly, we did not find an association between CSF SID and the modified Fisher scale score. This finding might be due to both the limited sample size and the fact that the modified Fisher scale score is based on a computed tomography scan obtained on the day of intensive care admission, whereas the samples are obtained a median of 2 days after bleeding, after the placement of an external ventricular drain.
Our data suggest that the response to a local CSF acidification might differ among patients with SAH and that cerebral metabolism, and therefore local CO2 production, might be an important variable. An additional clinical message of our study could be the following: patients with SAH with an external ventricular drain have an easy and safe access to CSF. This particular extracellular fluid (CSF) contains several physiologic information linked to spontaneous breathing activity and cerebral blood flow. In a patient population characterized by an acute neurologic condition, this fluid might even gain more importance, including, possibly, a prognostic role. Our limited sample size is of course insufficient to draw inferences about the prognostic role of a single value or of its time course. However, we think that it might be a good research question for future studies.

Limitations

We need to acknowledge some limitations of our study. First, a higher presence of men characterized our controls, as compared with the SAH population. Although hormones certainly play a role in respiratory regulation, this is more evident during pregnancy, which was an exclusion criterion for our study. Second, we sampled CSF in different sites, i.e., lumbar in controls and ventricular in patients with SAH. Differences in PCO2 and pH of the two sites are minimal in physiologic conditions [41]. Therefore, it is conceivable to consider the lumbar CSF samples of controls to be similar to their ventricular CSF.
On the contrary, meaningful differences between lumbar and ventricular CSF could be present in patients with SAH [29, 42, 43]. For this reason, we analyzed only ventricular CSF in patients with SAH because this is the extracellular fluid in close contact with the chemosensitive area [4446]. Moreover, we did not collect and report information regarding the type and amount of intravenous fluids administered to patients with SAH. As discussed above, intravenous fluid therapy might significantly alter the acid–base and electrolyte equilibrium of both blood and CSF [4751]. Finally, a potential source of variability among CSF samples could derive from the collection timing. The CSF samples of the SAH population were collected as soon as clinically feasible, i.e., reliant on the clinical decision to place an external ventricular drain.

Conclusions

Patients with SAH have a localized CSF acidosis, characterized by a reduced CSF SID and mainly caused by increased lactate concentrations. CSF PCO2 is reduced to restore a normal CSF pH. This compensatory mechanism might explain the high incidence of arterial HA in patients with spontaneous SAH.

Conflict of interest

The authors certify that they have no affiliations with or involvement in any organization or entity with any financial or nonfinancial interest in the subject matter discussed in this article.

Ethical approval/informed consent

The study protocol and the informed consent process were approved by the Ethical Committee Milano Area B (protocol number: 25_2017bis), and written informed or deferred consent was obtained from patients according to Italian regulation.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Anästhesiologie

Kombi-Abonnement

Mit e.Med Anästhesiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes AINS, den Premium-Inhalten der AINS-Fachzeitschriften, inklusive einer gedruckten AINS-Zeitschrift Ihrer Wahl.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Fencl V, Leith DE. Stewart’s quantitative acid-base chemistry: Applications in biology and medicine. Respir Physiol. 1993;91(1):1–16.PubMedCrossRef Fencl V, Leith DE. Stewart’s quantitative acid-base chemistry: Applications in biology and medicine. Respir Physiol. 1993;91(1):1–16.PubMedCrossRef
2.
Zurück zum Zitat Sakka L, Coll G, Chazal J. Anatomy and physiology of cerebrospinal fluid [Internet]. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128(6):309–16.PubMedCrossRef Sakka L, Coll G, Chazal J. Anatomy and physiology of cerebrospinal fluid [Internet]. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128(6):309–16.PubMedCrossRef
3.
Zurück zum Zitat Langer T, Zanella A, Caironi P. Understanding the role of the cerebrospinal fluid in acid–base disorders. Intensive Care Med. 2016;42(3):436–9.PubMedCrossRef Langer T, Zanella A, Caironi P. Understanding the role of the cerebrospinal fluid in acid–base disorders. Intensive Care Med. 2016;42(3):436–9.PubMedCrossRef
4.
Zurück zum Zitat Siesjö BK, Kjällquist Å, Pontén U, Zwetnow N. Extracellular pH in the brain and cerebral blood flow. Prog Brain Res. 1968;30:93–8.PubMedCrossRef Siesjö BK, Kjällquist Å, Pontén U, Zwetnow N. Extracellular pH in the brain and cerebral blood flow. Prog Brain Res. 1968;30:93–8.PubMedCrossRef
5.
Zurück zum Zitat Fencl V, Miller T, Pappenheimer. Studies on the respiratory response to disturbances of acid-base balance, with deductions concerning the ionic composition of cerebral interstitial fluid. Am J Physiol Content. 1966;210(3):459–72.CrossRef Fencl V, Miller T, Pappenheimer. Studies on the respiratory response to disturbances of acid-base balance, with deductions concerning the ionic composition of cerebral interstitial fluid. Am J Physiol Content. 1966;210(3):459–72.CrossRef
6.
Zurück zum Zitat Froman C, Smith AC. Hyperventilation associated with low pH of cerebrospinal fluid after intracranial haemorrhage. Lancet. 1966;1(7441):780–2.PubMedCrossRef Froman C, Smith AC. Hyperventilation associated with low pH of cerebrospinal fluid after intracranial haemorrhage. Lancet. 1966;1(7441):780–2.PubMedCrossRef
7.
Zurück zum Zitat Froman C, Smith AC. Metabolic acidosis of the cerebrospinal fluid associated with subarachnoid haemorrhage. Lancet. 1967;1(7497):965–7.PubMedCrossRef Froman C, Smith AC. Metabolic acidosis of the cerebrospinal fluid associated with subarachnoid haemorrhage. Lancet. 1967;1(7497):965–7.PubMedCrossRef
9.
Zurück zum Zitat Froman C. Alterations of respiratory function in patients with severe head injuries. Br J Anaesth. 1968;40(5):354–60.PubMedCrossRef Froman C. Alterations of respiratory function in patients with severe head injuries. Br J Anaesth. 1968;40(5):354–60.PubMedCrossRef
10.
Zurück zum Zitat Plum F, Swanson AG. Central Neurogenic Hyperventilation in Man. Arch Neurol Psychiatry. 1959;81(5):535–49.CrossRef Plum F, Swanson AG. Central Neurogenic Hyperventilation in Man. Arch Neurol Psychiatry. 1959;81(5):535–49.CrossRef
11.
Zurück zum Zitat Sambrook MA, Hutchinson EC, Aber GM. Metabolic studies in subarachnoid hæmorrhage and strokes. I: Serial changes in acid-base values in blood and cerebrospinal fluid. Brain. 1973;96(1):171–90.PubMedCrossRef Sambrook MA, Hutchinson EC, Aber GM. Metabolic studies in subarachnoid hæmorrhage and strokes. I: Serial changes in acid-base values in blood and cerebrospinal fluid. Brain. 1973;96(1):171–90.PubMedCrossRef
12.
Zurück zum Zitat Zoerle T, Lombardo A, Colombo A, et al. Intracranial pressure after subarachnoid hemorrhage. Crit Care Med. 2015;43(1):168–76.PubMedCrossRef Zoerle T, Lombardo A, Colombo A, et al. Intracranial pressure after subarachnoid hemorrhage. Crit Care Med. 2015;43(1):168–76.PubMedCrossRef
13.
Zurück zum Zitat Rosen DS, Macdonald RL. Subarachnoid hemorrhage grading scales: A systematic review. Neurocrit Care. 2005;2(2):110–8.PubMedCrossRef Rosen DS, Macdonald RL. Subarachnoid hemorrhage grading scales: A systematic review. Neurocrit Care. 2005;2(2):110–8.PubMedCrossRef
14.
Zurück zum Zitat Langer T, Carlesso E, Protti A, et al. In vivo conditioning of acid-base equilibrium by crystalloid solutions: An experimental study on pigs. Intens Care Med. 2012;38(4):686–93.CrossRef Langer T, Carlesso E, Protti A, et al. In vivo conditioning of acid-base equilibrium by crystalloid solutions: An experimental study on pigs. Intens Care Med. 2012;38(4):686–93.CrossRef
15.
Zurück zum Zitat Langer T, Ferrari M, Zazzeron L, Gattinoni L, Caironi P. Effects of intravenous solutions on acid-base equilibrium: from crystalloids to colloids and blood components. Rev Anaesthesiol Intensive Ther. 2014;46(5):350–60.CrossRef Langer T, Ferrari M, Zazzeron L, Gattinoni L, Caironi P. Effects of intravenous solutions on acid-base equilibrium: from crystalloids to colloids and blood components. Rev Anaesthesiol Intensive Ther. 2014;46(5):350–60.CrossRef
16.
Zurück zum Zitat Fencl V, Jabor A, Kazda A, Figge J. Diagnosis of metabolic acid-base disturbances in critically III patients. Am J Respir Crit Care Med. 2000;162(6):2246–51.PubMedCrossRef Fencl V, Jabor A, Kazda A, Figge J. Diagnosis of metabolic acid-base disturbances in critically III patients. Am J Respir Crit Care Med. 2000;162(6):2246–51.PubMedCrossRef
17.
Zurück zum Zitat Mitchell RA, Carman CT, Severinghaus JW, Richardson BW, Singer MM, Shnide S. Stability of cerebrospinal fluid pH in chronic acid-base disturbances in blood. J Appl Physiol. 1965;20(3):443–52.PubMedCrossRef Mitchell RA, Carman CT, Severinghaus JW, Richardson BW, Singer MM, Shnide S. Stability of cerebrospinal fluid pH in chronic acid-base disturbances in blood. J Appl Physiol. 1965;20(3):443–52.PubMedCrossRef
18.
Zurück zum Zitat Wilson JTL, Pettigrew LEL, Teasdale GM. Structured interviews for the glasgow outcome scale and the extended glasgow outcome scale: Guidelines for their use. J Neurotrauma. 1998;15(8):573–80.PubMedCrossRef Wilson JTL, Pettigrew LEL, Teasdale GM. Structured interviews for the glasgow outcome scale and the extended glasgow outcome scale: Guidelines for their use. J Neurotrauma. 1998;15(8):573–80.PubMedCrossRef
19.
Zurück zum Zitat Lu J, Marmarou A, Lapane K, Turf E, Wilson L. A method for reducing misclassification in the extended Glasgow Outcome Score. J Neurotrauma. 2010;27(5):843–52.PubMedPubMedCentralCrossRef Lu J, Marmarou A, Lapane K, Turf E, Wilson L. A method for reducing misclassification in the extended Glasgow Outcome Score. J Neurotrauma. 2010;27(5):843–52.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Greenberg ED, Gobin YP, Riina H, et al. Role of CT perfusion imaging in the diagnosis and treatment of vasospasm. Imaging Med. 2011;3(3):287–97.PubMedPubMedCentralCrossRef Greenberg ED, Gobin YP, Riina H, et al. Role of CT perfusion imaging in the diagnosis and treatment of vasospasm. Imaging Med. 2011;3(3):287–97.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Wijdicks EFM. Recording Neurogenic Breathing Patterns in Acute Brain Injury. Neurocrit Care. 2021;34(2):674–6.PubMedCrossRef Wijdicks EFM. Recording Neurogenic Breathing Patterns in Acute Brain Injury. Neurocrit Care. 2021;34(2):674–6.PubMedCrossRef
22.
Zurück zum Zitat Leusen IR. Chemosensitivity of the respiratory center. Am J Physiol Content. 1953;176(1):39–44.CrossRef Leusen IR. Chemosensitivity of the respiratory center. Am J Physiol Content. 1953;176(1):39–44.CrossRef
23.
Zurück zum Zitat Pappenheimer JR, Fencl V, Heisey SR, Held D. Role of cerebral fluids in control of respiration as studied in unanesthetized goats. Am J Physiol Content. 1965;208(3):436–50.CrossRef Pappenheimer JR, Fencl V, Heisey SR, Held D. Role of cerebral fluids in control of respiration as studied in unanesthetized goats. Am J Physiol Content. 1965;208(3):436–50.CrossRef
24.
Zurück zum Zitat Leusen I. Regulation of cerebrospinal fluid composition with reference to breathing. Physiol Rev. 1972;52(1):1–56.PubMedCrossRef Leusen I. Regulation of cerebrospinal fluid composition with reference to breathing. Physiol Rev. 1972;52(1):1–56.PubMedCrossRef
25.
Zurück zum Zitat Mascheroni D, Kolobow T, Fumagalli R, Moretti MP, Chen V, Buckhold D. Acute respiratory failure following pharmacologically induced hyperventilation: an experimental animal study. Intens Care Med. 1988;15(1):8–14.CrossRef Mascheroni D, Kolobow T, Fumagalli R, Moretti MP, Chen V, Buckhold D. Acute respiratory failure following pharmacologically induced hyperventilation: an experimental animal study. Intens Care Med. 1988;15(1):8–14.CrossRef
26.
Zurück zum Zitat Choma L, Kazemi H. Importance of changes in plasma HCO3- on regulation of CSF HCO3- in respiratory alkalosis. Respir Physiol. 1976;26(2):265–78.PubMedCrossRef Choma L, Kazemi H. Importance of changes in plasma HCO3- on regulation of CSF HCO3- in respiratory alkalosis. Respir Physiol. 1976;26(2):265–78.PubMedCrossRef
27.
Zurück zum Zitat Kazemi H, Johnson DC. Regulation of cerebrospinal fluid acid-base balance. Physiol Rev. 1986;66(4):953–1037.PubMedCrossRef Kazemi H, Johnson DC. Regulation of cerebrospinal fluid acid-base balance. Physiol Rev. 1986;66(4):953–1037.PubMedCrossRef
28.
Zurück zum Zitat Kazemi H. Regulation of CSF composition- blocking chloride-bicarbonate exchange. 2018; Kazemi H. Regulation of CSF composition- blocking chloride-bicarbonate exchange. 2018;
29.
Zurück zum Zitat Rossanda M, Sganzerla EP. Acid-base and gas tension measurements in cerebrospinal fluid. Br J Anaesth. 1976;48(8):753–60.PubMedCrossRef Rossanda M, Sganzerla EP. Acid-base and gas tension measurements in cerebrospinal fluid. Br J Anaesth. 1976;48(8):753–60.PubMedCrossRef
30.
Zurück zum Zitat Yatsu FM, Lee LW, Liao CL. Energy metabolism during brain ischemia: stability during reversible and irreversible damage. Stroke. 1975;6(6):678–83.PubMedCrossRef Yatsu FM, Lee LW, Liao CL. Energy metabolism during brain ischemia: stability during reversible and irreversible damage. Stroke. 1975;6(6):678–83.PubMedCrossRef
31.
Zurück zum Zitat Mendelow AD, McCalden TA, Hattingh J, Coull A, Rosendorff C, Eldelman BH. Cerebrovascular reactivity and metabolism after subarachnoid hemorrhage in Baboons. Stroke. 1981;12(1):58–65.PubMedCrossRef Mendelow AD, McCalden TA, Hattingh J, Coull A, Rosendorff C, Eldelman BH. Cerebrovascular reactivity and metabolism after subarachnoid hemorrhage in Baboons. Stroke. 1981;12(1):58–65.PubMedCrossRef
32.
33.
Zurück zum Zitat Fujishima M, Sugi T. Cerebrospinal fluid and arterial lactate, pyruvate and acid-base balance in patients with intracranial hemorrhages. Stroke. 1975;6(6):707–14.PubMedCrossRef Fujishima M, Sugi T. Cerebrospinal fluid and arterial lactate, pyruvate and acid-base balance in patients with intracranial hemorrhages. Stroke. 1975;6(6):707–14.PubMedCrossRef
34.
Zurück zum Zitat Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7(8):728–41.PubMedCrossRef Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7(8):728–41.PubMedCrossRef
35.
Zurück zum Zitat Langer T, Brusatori S, Carlesso E, et al. Low noncarbonic buffer power amplifies acute respiratory acid-base disorders in patients with sepsis: an in vitro study. J Appl Physiol. 2021;131(2):464–73.PubMedCrossRef Langer T, Brusatori S, Carlesso E, et al. Low noncarbonic buffer power amplifies acute respiratory acid-base disorders in patients with sepsis: an in vitro study. J Appl Physiol. 2021;131(2):464–73.PubMedCrossRef
36.
Zurück zum Zitat The SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357(9):874–84.CrossRef The SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357(9):874–84.CrossRef
37.
Zurück zum Zitat Suarez JI, Martin RH, Calvillo E, et al. The albumin in subarachnoid hemorrhage (ALISAH) multicenter pilot clinical trial. Stroke. 2012;43(3):683–90.PubMedPubMedCentralCrossRef Suarez JI, Martin RH, Calvillo E, et al. The albumin in subarachnoid hemorrhage (ALISAH) multicenter pilot clinical trial. Stroke. 2012;43(3):683–90.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Krapf R, Beeler I, Hertner D, Hulter HN. Chronic respiratory alkalosis. N Engl J Med. 1991;324(20):1394–401.PubMedCrossRef Krapf R, Beeler I, Hertner D, Hulter HN. Chronic respiratory alkalosis. N Engl J Med. 1991;324(20):1394–401.PubMedCrossRef
39.
Zurück zum Zitat Carpenter DA, Grubb RL, Tempel LW, Powers WJ. Cerebral oxygen metabolism after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1991;11(5):837–44.PubMedCrossRef Carpenter DA, Grubb RL, Tempel LW, Powers WJ. Cerebral oxygen metabolism after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1991;11(5):837–44.PubMedCrossRef
40.
Zurück zum Zitat Solaiman O, Singh JM. Hypocapnia in aneurysmal subarachnoid hemorrhage: Incidence and association with poor clinical outcomes. J Neurosurg Anesthesiol. 2013;25(3):254–61.PubMedCrossRef Solaiman O, Singh JM. Hypocapnia in aneurysmal subarachnoid hemorrhage: Incidence and association with poor clinical outcomes. J Neurosurg Anesthesiol. 2013;25(3):254–61.PubMedCrossRef
41.
Zurück zum Zitat van Heijst ANP, Maas AHJ, Visser BF. Comparison of the acid-base balance in cisternal and lumbar cerebrospinal fluid. Pflugers Arch Gesamte Physiol Menschen Tiere. 1966;287(3):242–6.PubMedCrossRef van Heijst ANP, Maas AHJ, Visser BF. Comparison of the acid-base balance in cisternal and lumbar cerebrospinal fluid. Pflugers Arch Gesamte Physiol Menschen Tiere. 1966;287(3):242–6.PubMedCrossRef
42.
Zurück zum Zitat Shimoda M, Yamada S, Yamamoto I, Tsugane R, Sato O. Time course of csf lactate level in subarachnoid haemorrhage correlation with clinical grading and prognosis. Acta Neurochir (Wien) 1989; Shimoda M, Yamada S, Yamamoto I, Tsugane R, Sato O. Time course of csf lactate level in subarachnoid haemorrhage correlation with clinical grading and prognosis. Acta Neurochir (Wien) 1989;
43.
Zurück zum Zitat Plum F, Price RW. Acid-Base Balance of Cisternal and Lumbar Cerebrospinal Fluid in Hospital Patients. N Engl J Med. 1973;289(25):1346–51.PubMedCrossRef Plum F, Price RW. Acid-Base Balance of Cisternal and Lumbar Cerebrospinal Fluid in Hospital Patients. N Engl J Med. 1973;289(25):1346–51.PubMedCrossRef
44.
Zurück zum Zitat Mitchell RA, Loeschcke HH, Massion WH, Severinghaus JW. Respiratory responses mediated through superficial chemosensitive areas on the medulla. J Appl Physiol. 1963;18(3):523–33.PubMedCrossRef Mitchell RA, Loeschcke HH, Massion WH, Severinghaus JW. Respiratory responses mediated through superficial chemosensitive areas on the medulla. J Appl Physiol. 1963;18(3):523–33.PubMedCrossRef
45.
Zurück zum Zitat Kiley JP, Eldridge FL, Millhorn DE. The roles of medullary extracellular and cerebrospinal fluid pH in control of respiration. Respir Physiol. 1985;59(2):117–30.PubMedCrossRef Kiley JP, Eldridge FL, Millhorn DE. The roles of medullary extracellular and cerebrospinal fluid pH in control of respiration. Respir Physiol. 1985;59(2):117–30.PubMedCrossRef
47.
Zurück zum Zitat Monroe CB, Kazemi H. Effect of changes in plasma bicarbonate level on CSF bicarbonate in respiratory acidosis. Respir Physiol. 1973;17(3):386–93.PubMedCrossRef Monroe CB, Kazemi H. Effect of changes in plasma bicarbonate level on CSF bicarbonate in respiratory acidosis. Respir Physiol. 1973;17(3):386–93.PubMedCrossRef
48.
49.
Zurück zum Zitat Kilic O, Gultekin Y, Yazici S. The impact of intravenous fluid therapy on acidbase status of critically ill adults: A stewart approach-based perspective. Int J Nephrol Renovasc Dis. 2020;13:219–30.PubMedPubMedCentralCrossRef Kilic O, Gultekin Y, Yazici S. The impact of intravenous fluid therapy on acidbase status of critically ill adults: A stewart approach-based perspective. Int J Nephrol Renovasc Dis. 2020;13:219–30.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Rundgren M, Jonasson H, Hjelmqvist H. Water intake and changes in plasma and CSF composition in response to acute administration of hypertonic NaCl and water deprivation in sheep. Acta Physiol Scand. 1990;138(1):85–92.PubMedCrossRef Rundgren M, Jonasson H, Hjelmqvist H. Water intake and changes in plasma and CSF composition in response to acute administration of hypertonic NaCl and water deprivation in sheep. Acta Physiol Scand. 1990;138(1):85–92.PubMedCrossRef
51.
Zurück zum Zitat Langer T, Santini A, Scotti E, Van Regenmortel N, Malbrain MLNG, Caironi P. Intravenous balanced solutions: From physiology to clinical evidence. Anaesthesiol Intensive Ther. 2015;47(1):s78-88.PubMedCrossRef Langer T, Santini A, Scotti E, Van Regenmortel N, Malbrain MLNG, Caironi P. Intravenous balanced solutions: From physiology to clinical evidence. Anaesthesiol Intensive Ther. 2015;47(1):s78-88.PubMedCrossRef
Metadaten
Titel
Cerebrospinal Fluid and Arterial Acid–Base Equilibrium of Spontaneously Breathing Patients with Aneurismal Subarachnoid Hemorrhage
verfasst von
Thomas Langer
Francesco Zadek
Marco Carbonara
Alessio Caccioppola
Serena Brusatori
Tommaso Zoerle
Francesco Bottazzini
Chiara Ferraris Fusarini
Adriana di Modugno
Alberto Zanella
Elisa R. Zanier
Roberto Fumagalli
Antonio Pesenti
Nino Stocchetti
Publikationsdatum
23.02.2022
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 1/2022
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-022-01450-1

Weitere Artikel der Ausgabe 1/2022

Neurocritical Care 1/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.